• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国国家健康筛查队列研究:肥胖 II 级人群减肥对疾病总体负担的长期影响

Long-term impact of weight loss in people with class II obesity on the overall burden of disease: Evidence from the National Health Screening Cohort in Korea.

机构信息

Department of Surgery, Seoul National University Hospital, Seoul, Korea; Department of Surgery, Gachon University College of Medicine, Gachon University Gil Medical Center, Incheon, Korea.

Department of Surgery, Seoul National University Hospital, Seoul, Korea; Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Surg Obes Relat Dis. 2024 Jul;20(7):695-704. doi: 10.1016/j.soard.2024.01.014. Epub 2024 Jan 30.

DOI:10.1016/j.soard.2024.01.014
PMID:38418337
Abstract

BACKGROUND

Obesity is known to increase overall disease burden but does obesity management actually help reduce disease burden?

OBJECTIVES

To investigate the effects of weight loss on disease burden in people with obesity using the National Health Insurance Service-Health Screening Cohort (NHIS-HEALS) in Korea.

SETTING

Pure longitudinal observational study using Nationwide cohort database.

METHODS

Out of 514,866 NHIS-HEALS cohort, participants with class II obesity in Asia-Pacific region (30 ≤ body mass index [BMI] < 35) who underwent health check-up provided by NHIS during 2003-2004 (index date) were included. All final participants continued to receive a total of 5 biennial health check-ups over the next 10 years without missing. A group-based trajectory model (GBTM) was used to categorize subjects based on 10-year BMI change patterns. The changes of co-morbidities, healthcare resource utilization, and medical cost were analyzed.

RESULTS

The final study subjects (9857) were categorized into 3 trajectory clusters based on the pattern of BMI (kg/m) change: maintenance (57.35%) with an average change of -.02 ± .06, loss (38.65%) with -.04 ± .08, and substantial loss (4.0%) with -.10 ± .18. The annual increases in the number of co-morbidities per subject in each cluster were .18, .18, and .16 (all P < .001), respectively. The increase of healthcare resource utilization over time was lowest for the substantial loss compared to maintenance and loss. With each passing year, the average annual total healthcare cost increased by ₩21,200 ($16.48, P = .034) and ₩10,500 ($8.16, P = .498) in the maintenance and loss, respectively, but decreased by ₩62,500 ($48.59, P = .032) in the substantial loss.

CONCLUSIONS

Weight loss in people with obesity was associated with a reduced burden of disease, as evidenced by lower co-morbidity, healthcare resource utilization rate, and decreased medical costs. This study highlights the potential positive long-term impact on Korean society when actively managing weight in individuals with obesity.

摘要

背景

肥胖已知会增加整体疾病负担,但肥胖管理实际上是否有助于减轻疾病负担?

目的

使用韩国国民健康保险服务-健康筛查队列(NHIS-HEALS)研究减肥对肥胖人群疾病负担的影响。

设置

使用全国队列数据库进行纯纵向观察研究。

方法

从 NHIS-HEALS 队列的 514866 名参与者中,纳入亚太地区(30≤BMI<35)II 类肥胖的参与者,他们在 2003-2004 年(索引日期)期间接受了 NHIS 提供的健康检查。所有最终参与者在接下来的 10 年内继续总共接受 5 次两年一次的健康检查,没有遗漏。使用基于群组的轨迹模型(GBTM)根据 10 年 BMI 变化模式对受试者进行分类。分析了合并症、医疗资源利用和医疗费用的变化。

结果

最终研究对象(9857 人)根据 BMI(kg/m)变化模式分为 3 个轨迹群:维持组(57.35%)平均变化为-.02±.06,减轻组(38.65%)为-.04±.08,大量减轻组(4.0%)为-.10±.18。每个群组中每个受试者每年合并症数量的增加分别为.18、.18 和.16(均 P<.001)。与维持组和减轻组相比,大量减轻组的医疗资源利用增加率最低。随着时间的推移,维持组和减轻组的患者每年的平均总医疗费用分别增加₩21200(16.48 美元,P=0.034)和₩10500(8.16 美元,P=0.498),而大量减轻组则减少₩62500(48.59 美元,P=0.032)。

结论

肥胖患者减肥与疾病负担减轻相关,表现为合并症、医疗资源利用率降低和医疗费用减少。本研究强调了在韩国社会积极管理肥胖人群体重时可能产生的长期积极影响。

相似文献

1
Long-term impact of weight loss in people with class II obesity on the overall burden of disease: Evidence from the National Health Screening Cohort in Korea.韩国国家健康筛查队列研究:肥胖 II 级人群减肥对疾病总体负担的长期影响
Surg Obes Relat Dis. 2024 Jul;20(7):695-704. doi: 10.1016/j.soard.2024.01.014. Epub 2024 Jan 30.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
4
Surgery for weight loss in adults.成人减肥手术。
Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4.
5
Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson's Disease.体重指数变化与帕金森病全因死亡率的关系。
J Parkinsons Dis. 2024;14(7):1441-1450. doi: 10.3233/JPD-240181.
6
Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity.改变卫生专业人员行为及护理组织方式的干预措施,以促进超重或肥胖儿童及成人减轻体重。
Cochrane Database Syst Rev. 2017 Nov 30;11(11):CD000984. doi: 10.1002/14651858.CD000984.pub3.
7
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.在初级保健中使用药物治疗肥胖患者的临床效果和成本效益如何?系统评价。
Health Technol Assess. 2012;16(5):iii-xiv, 1-195. doi: 10.3310/hta16050.
8
Mobile health (m-health) smartphone interventions for adolescents and adults with overweight or obesity.移动健康(m-health)智能手机干预措施用于超重或肥胖的青少年和成年人。
Cochrane Database Syst Rev. 2024 Feb 20;2(2):CD013591. doi: 10.1002/14651858.CD013591.pub2.
9
Impact of semaglutide 2.4 mg on healthcare resource utilization and medical costs in patients with atherosclerotic cardiovascular disease in the United States (SHINE-ASCVD).司美格鲁肽2.4毫克对美国动脉粥样硬化性心血管疾病患者医疗资源利用和医疗费用的影响(SHINE-ASCVD研究)
J Med Econ. 2025 Dec;28(1):1075-1085. doi: 10.1080/13696998.2025.2526282. Epub 2025 Jul 12.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

引用本文的文献

1
Association Between Fatty Liver Index and Incidence of Cataract Surgery in Individuals Aged 50 Years and Older Based on the Korean National Health Insurance Service-Health Screening Cohort (NHIS-HEALS) Data: Longitudinal Retrospective Cohort Study.基于韩国国民健康保险服务-健康筛查队列(NHIS-HEALS)数据的 50 岁及以上人群中脂肪肝指数与白内障手术发生率的相关性:纵向回顾性队列研究。
JMIR Public Health Surveill. 2024 Nov 14;10:e57168. doi: 10.2196/57168.